Your shopping cart is currently empty

Cardionogen-2 is a biphasic cardiac regulatory agent that can either promote or inhibit heart formation depending on the intervention stage. It inhibits Wnt/β-catenin-dependent transcription in mouse embryonic stem cells and zebrafish embryos.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Cardionogen-2 is a biphasic cardiac regulatory agent that can either promote or inhibit heart formation depending on the intervention stage. It inhibits Wnt/β-catenin-dependent transcription in mouse embryonic stem cells and zebrafish embryos. |
| In vitro | Cardionogen-2 enhances cardiac formation during and after gastrulation in zebrafish embryos and mouse embryonic stem cells (ES), while it inhibits cardiac formation before gastrulation. The effects induced by Cardionogen-2 are counteracted by enhancing Wnt/β-catenin signaling activity. Cardionogen-2 suppresses Wnt/β-catenin-dependent transcription in mouse ES cells and zebrafish embryos [1]. |
| Molecular Weight | 339.372 |
| Formula | C16H13N5O2S |
| Cas No. | 578755-52-9 |
| Smiles | N=1N=C(C=2N=CC=CC2)N3N=C(SC13)C=4C=CC(OC)=C(OC)C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.